Injectables - Plastic Surgery Internal

RECOMMENDED READING
Alam M, Gladstone H, Kramer EM, Murphy JP Jr, Nouri K,
Neuhaus IM, Spencer JM, Spenceri E, Van Dyke S, Ceilley
RI, Lee KK, Menaker G, Monheit GD, Orentreich DS, Raab
B, Smith KC, Solish NJ. ASDS guidelines of care: Injectable
fillers. Dermatol Surg 2008;34[suppl 1]:S115–S148.
Bailey S, Cohen J, Kenkel JM. Etiology, prevention and
treatment of dermal filler complications. Aesthet Surg J 2010,
in press.
Baumann L, Brandt FS, Kane MA, Donofrio LM. An analysis
of efficacy data from four phase III studies of botulinum
neurotoxin type A-ABO for the treatment of glabellar lines.
Aesthet Surg J 2009;29[suppl 6]:S57–S65.
Broughton G II, Crosby MA, Coleman J, Rohrich RJ. Use
of herbal supplements and vitamins in plastic surgery: A
practical review. Plast Reconstr Surg 2007;119:48e–66e.
Carruthers A, Carruthers J. Clinical indications and injection
technique for the cosmetic use of botulinum A exotoxin.
Dermatol Surg 1998;24:1189–1194.
Carruthers J, Fagien S, Matarasso SL. Consensus
recommendations on the use of botulinum toxin type A
in facial aesthetics. Plast Reconstr Surg 2004;114
[suppl 6]:1S–22S.
Carruthers JD, Glogau RG, Blitzer A. Advances in facial
rejuvenation: Botulinum toxin type A, hyaluronic acid
dermal fillers, and combination therapies: Consensus
recommendations. Plast Reconstr Surg 2008;121[suppl
5]:5S–30S.
Cohen JL. Understanding, avoiding, and managing dermal
filler complications. Dermatol Surg 2008;34[suppl 1]:
S92–S99.
Coleman SR. Structural fat grafting. Aesthet Surg J
1998;18:386, 388.
SRPS • Volume 10 • Issue 28 • 2010
Kane MA, Brandt F, Rohrich RJ, Narins RS, Monheit GD,
Huber MB. Evaluation of variable-dose treatment with a
new U.S. botulinum toxin type A (Dysport) for correction of
moderate to severe glabellar lines: Results from a phase III,
randomized, double-blind, placebo-controlled study. Plast
Reconstr Surg 2009;124:1619–1629.
Klein AW. Complications, adverse reactions, and
insights with the use of botulinum toxin. Dermatol Surg
2003;29:549–556.
Lemperle G, Gauthier-Hazan N. Foreign body granulomas
after all injectable dermal fillers: Part 2. Treatment options.
Plast Reconstr Surg 2009;123:1864–1873.
Lemperle G, Gauthier-Hazan N, Wolters M, Eisemann-Klein
M, Zimmermann U, Duffy DM. Foreign body granulomas
after all injectable dermal fillers: Part 1. Possible causes. Plast
Reconstr Surg 2009;123:1842–1863.
Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and
treating dermal filler complications. Plast Reconstr Surg
2006;118[suppl 3]:92S–107S.
Rohrich RJ, Monheit GD, Nguyen AT, Brown SA, Fagien
S. Soft tissue filler complications: The important role of
biofilms. Plast Reconstr Surg 2010;125:1250–1256.
Rohrich R J, Nguyen AT, Kenkel JM. Lexicon for soft tissue
implants. Dermatol Surg 2009;35[suppl 2]:1605–1611.
Rohrich RJ, Pessa JE. The fat compartments of the face:
Anatomy and clinical implications for cosmetic surgery. Plast
Reconstr Surg 2007;119:2219–2227.
Rubin M, Dover J, Maas C, Nestor M. An analysis of safety
data from five phase III clinical trials on the use of botulinum
neurotoxin type A-ABO for the treatment of glabellar lines.
Aesthet Surg J 2009;29[suppl 6]:S50–S56.
25